SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-228009
Filing Date
2019-08-23
Accepted
2019-08-23 17:03:03
Documents
6
Period of Report
2019-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d768153d8k.htm 8-K 23629
2 EX-5.1 d768153dex51.htm EX-5.1 5841
3 EX-10.1 d768153dex101.htm EX-10.1 202953
4 GRAPHIC g768153g37j13.gif GRAPHIC 2222
5 GRAPHIC g768153g47d13.gif GRAPHIC 4190
6 GRAPHIC g768153g90w41.gif GRAPHIC 5498
  Complete submission text file 0001193125-19-228009.txt   250104
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 191049809
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences